Hormonal
Younger adults (18-44 years) with Type 2 Diabetes and obesity exhibit significantly higher rates of poor glycemic control compared to older adults, despite having higher mean BMI and waist circumference.
If you are under 45 and have Type 2 Diabetes, your blood sugar control is likely worse than older patients with the disease, especially if you carry extra weight around your waist. You need to prioritize weight management and dietary habits more aggressively than older patients to achieve similar glycemic targets.
More than 58% of people in the 18–44 years age group with central obesity had poor glycemic control.
Why this rating
Large sample size within the subgroup, but observational nature limits causal inference regarding age-specific mechanisms.
Source
Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study
Kazuo Hara et al. · Diabetes Therapy · 2024
DOI 10.1007/s13300-024-01543-4
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →